Bank Pictet & Cie (Europe) AG has added 112,421 shares of $ABBV to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $ABBV.
ABBVIE Hedge Fund Activity
We have seen 1,823 institutional investors add shares of ABBVIE stock to their portfolio, and 1,614 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 9,691,073 shares (-59.9%) from their portfolio in Q2 2025, for an estimated $1,798,856,970
- CAPITAL RESEARCH GLOBAL INVESTORS removed 8,242,435 shares (-24.6%) from their portfolio in Q2 2025, for an estimated $1,529,960,784
- CAPITAL INTERNATIONAL INVESTORS removed 6,885,308 shares (-33.5%) from their portfolio in Q2 2025, for an estimated $1,278,050,870
- VANGUARD GROUP INC added 3,380,842 shares (+1.9%) to their portfolio in Q2 2025, for an estimated $627,551,892
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 3,134,454 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $725,751,479
- AMERIPRISE FINANCIAL INC removed 3,127,890 shares (-25.2%) from their portfolio in Q2 2025, for an estimated $580,598,941
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 2,969,202 shares (+169.3%) to their portfolio in Q2 2025, for an estimated $551,143,275
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ABBVIE Insider Trading Activity
ABBVIE insiders have traded $ABBV stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- AZITA SALEKI-GERHARDT (EVP, CHIEF OPERATIONS OFFICER) sold 42,370 shares for an estimated $8,407,055
- NICHOLAS DONOGHOE (EVP, CHIEF BUS/STRAT OFFICER) has made 0 purchases and 2 sales selling 13,295 shares for an estimated $2,639,252.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ABBVIE Government Contracts
We have seen $487,443 of award payments to $ABBV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANTS: $36,934
- IMPLANT: $35,788
- 4567253744!NATRELLE TE SMOOTH 133S-SV-13-T: $33,629
- IMPLANTS: $29,604
- PROSTHETIC ORDER - IMPLANT ITEMS: $15,758
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ABBVIE Congressional Stock Trading
Members of Congress have traded $ABBV stock 11 times in the past 6 months. Of those trades, 6 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 08/22, 08/11.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 08/04, 05/05 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 07/22, 06/17 and 1 sale worth up to $15,000 on 07/22.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 05/22.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ABBVIE Analyst Ratings
Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 10/20/2025
- Piper Sandler issued a "Overweight" rating on 10/10/2025
- Cantor Fitzgerald issued a "Overweight" rating on 09/15/2025
- BMO Capital issued a "Outperform" rating on 09/12/2025
- Raymond James issued a "Outperform" rating on 04/28/2025
- Evercore ISI Group issued a "Outperform" rating on 04/28/2025
- Morgan Stanley issued a "Overweight" rating on 04/28/2025
To track analyst ratings and price targets for ABBVIE, check out Quiver Quantitative's $ABBV forecast page.
ABBVIE Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 13 analysts offer price targets for $ABBV in the last 6 months, with a median target of $245.0.
Here are some recent targets:
- Vamil Divan from Guggenheim set a target price of $242.0 on 10/20/2025
- Gary Nachman from Raymond James set a target price of $250.0 on 10/17/2025
- Christopher Raymond from Piper Sandler set a target price of $284.0 on 10/10/2025
- Geoff Meacham from B of A Securities set a target price of $251.0 on 10/03/2025
- Gavin Clark-Gartner from Evercore ISI Group set a target price of $222.0 on 09/22/2025
- Luisa Hector from Berenberg set a target price of $270.0 on 09/17/2025
- Chris Schott from JP Morgan set a target price of $235.0 on 09/16/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $ABBV ticker page for more data.
